Sunday, May 15, 2005

Top 10- 20 Big Pharma

yahoo finance Big Pharma Leaders/ Laggards based on revenue
as of 15May05...

Top 10 Big Pharma based on revenue...

1- PFIZER INC [PFE]...................................$53.1 B
2- JOHNSON AND JOHNS DC [JNJ]...................$48.6 B
3- GLAXOSMITHKLINE PLC [GSK] ....................$37.9 B
4- BAYER AKTIENGES ADS [BAY] ....................$36.8 B
5- NOVARTIS AG ADS [NVS] ..........................$29.0 B
6- ROCHE HLDG LTD SPONS [RHHBY.PK] ..........$25.6 B
7- MERCK CO INC [MRK] .............................$22.7 B
8- ASTRAZENECA PLC ADS [AZN] ...................$22.1 B
9- ABBOTT LABORATORIES [ABT] ..................$20.4 B
10- BRISTOL MYERS SQIBB [BMY] ...................$19.3 B


Laggards in Total Revenue (ttm)

9- ABBOTT LABORATORIES [ABT] ...................$20.4 B
10- BRISTOL MYERS SQIBB [BMY] ...................$19.3 B
11- WYETH [WYE] ....................................$17.9 B
12- LILLY ELI CO [LLY] ..............................$14.0 B
13- SCHERING PLOUGH CP [SGP] ...................$8.7 B
14- SCHERING AKTIENGESEL [SHR] .................$6.3 B
15- ALCON INC [ACL] .................................$4.0 B
16- PRESTIGE BRAND HLGS [PBH] ................$303.3 M
17- NOVADEL PHARMA INC [NVD] .................$685.0 K
18- APPLIED NEUROSOLUTNS [APNS.OB] .........$253.0 K

I guess I'm surprised to see the overlap between the Top 10 Leaders and the Laggards...only to the extent that it shows 15 companies measure revenue in the billions...and it falls off rapidly after that.

How do we get from the largest drug companies in the world to over the counter trading in 18 spots on this list?

and we didn't stretch it to a full 20 companies...

No comments: